Impact of FLT3 internal tandem duplications on Indian acute promyelocytic leukemia patients: Prognostic implications

Hematology

Volumn 12, Issue 2, 2007, Pages 99-101

  Hasan, Syed K ^a   Sazawal, Sudha ^a   Dutta, Pankhi ^b   Pillai, Lakshmi ^a   Kumar, Bijender ^a   Chaubey, Rekha ^a   Kumar, Rajat ^a   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

APL; FLT3 ITD; PML RAR ; RT PCR

Indexed keywords

ANTINEOPLASTIC AGENT; BREAKPOINT CLUSTER REGION PROTEIN; CD135 ANTIGEN; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PROTEIN BCR1; PROTEIN BCR3; RETINOIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE DUPLICATION; GENE FUNCTION; GENE MUTATION; HUMAN; INDIAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; SCHOOL CHILD; SEX RATIO; TANDEM REPEAT; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DAUNORUBICIN; FEMALE; FMS-LIKE TYROSINE KINASE 3; FOLLOW-UP STUDIES; GENE DUPLICATION; HUMANS; INDIA; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTE COUNT; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROGNOSIS; REMISSION INDUCTION; TANDEM REPEAT SEQUENCES; TREATMENT OUTCOME; TRETINOIN;

EID: 34247198982     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330601111813     Document Type: Article

References (11)

1. Rosnet, O., Schiff, C., Pebusque, MJ, Marchetto, S., Tonnelle, C. and Toiron, Y. (1993) Human FLT3/FLK2 gene: CDNA cloning and expression in hematopoietic cells. Blood, 82, pp. 1110-1119.
2. Boissel, N., Cayuela, JM, Preudhomme, C., Thomas, X., Grardel, N., Fund, X. and Tigaud, I. (2002) Prognostic significance of FLT3 internal tandem repeat in patients with denovo acute myeloid leukemia treated with reinforced courses of chemotherapy. Leukemia, 16, pp. 1699-1704.
3. Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., Loffler, H. and Sauerland, CM (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 100, pp. 59-66.
4. Kiyoi, H., Naoe, T., Yokota, S., Nakao, M., Minami, S., Kuriyama, K., Takeshita, A. and Saito, K. (1997) Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia study group of the ministry of health and welfare (Kohseisho). Leukemia, 11, pp. 1447-1452.
5. Sanz, MA, Martin, G., Rayon, C., Esteve, J., Gonzalez, M., Diaz-Mediavilla, J., Bolufer, P. and Barragan, E. (1999) A modified AIDA protocol with anthracycline based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARA positive acute promyelocytic leukemia. Blood, 9, pp. 3015-3021.
6. Chomczynsky, P. and Sacchi, N. (1987) Single step method of RNA isolation by acid guanidium thocyanate-phenol chloroform extraction. Anal Biochem, 162, pp. 156-159.
7. Borrow, J., Goddard, AD, Gibbons, B., Katz, F., Swirsky, D., Fioretos, T., Dube, I. and Winfield, DA (1992) Diagnosis of acute promyelocytic leukemia by RT-PCR: Detection of PML-RARA and RARA-PML fusion transcripts. Br J Haematol, 82, pp. 529-540.
8. Noguera, NI, Breccia, M., Divona, M., Diverio, D., Costa, V. and De Santis, S. (2002) Alterations of the FLT3 gene in acute promyelocytic leucemia: Association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia, 16, pp. 2185-2189.
9. Shih, LY, Kuo, MC, Liang, DC, Huang, CF, Lin, TL, Wu, JH and Wang, PN (2003) Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3(FLT3) gene in acute promyelocytic leukemia. Cancer, 98, pp. 1206-1216.
10. Kainz, B., Heintel, D., Marculescu, R., Schwarzinger, I., Sperr, W., Welterman, A., Fontasch, C. and Haas, OA (2002) Variable prognostic value of FLT3 internal tandem dulications in patients with denovo AML and a normal karyotype, t(15;17), t(8;21) or inv16. Hematol J, 3, pp. 283-289.
11. Grimdade, D., Gale, R., Hills, R., Kottaridis, P., Swirsky, D., Gilkes, A., Nugent, E. and Mills, K. (2003) The relationship between FLT3 mutation status, biological characteristics and outcome in patients with acute promyelocytic leukemia. Blood, 102